AOD 9604 is a pharmaceutical option designed for individuals seeking to enhance their physical activity levels in support of weight loss. AOD 9604 may specifically target stubborn fat regions, such as abdominal fat, potentially making it useful for spot reduction. Additionally, this peptide may have the potential to increase muscle mass, boost the levels of insulin-like growth factor-1 (IGF-1), which can help metabolise fat, and accelerate metabolism. AOD 9604 has also shown promise in improving symptoms of osteoarthritis. It may increase the production of cartilage and collagen, leading to increased cartilage thickness and aiding in bone repair. This peptide can be administered through injection or transdermal cream application. 

Prescription-Only Medication Notice:
This peptide is a Schedule 4 prescription-only treatment. Selecting this product does not guarantee access or approval. All patients must undergo a consultation with an AHPRA-registered medical practitioner, who will assess clinical suitability and determine whether this treatment is appropriate. Prescriptions are issued only when medically justified and in line with regulatory guidelines.

**All peptide therapies available through PHYX require a medical consultation and prescription. Treatment suitability is determined by an AHPRA-registered clinician.**